X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Cadila Healthcare Fact Sheet, Cadila Healthcare Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Cadila Healthcare Fact Sheet   (CADIL)

Here is the latest financial fact sheet of Cadila Healthcare. For more details, see the Cadila Healthcare quarterly results and Cadila Healthcare share price and chart. For a sector overview, read our pharmaceuticals sector report.

CADILA HEALTHCARE Price History

Price Rs 376.5
Mkt Cap Rs m 385,438
Vol '000 739.4
P/E X 18.6
P/CF X 16.7
EPS (TTM) Rs 20.2
% ch % 5.5
No. of shares m 1,023.74
% ch week % 0.0
% ch 1-mth % 4.7
% ch 12-mth % -21.9
52 week H/L Rs 519.9/332.9
(As on Aug 20, 2018 03:37:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

CADILA HEALTHCARE Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
CADILA HEALTHCARE EQUITY SHARE DATA
High Rs1,0791,763454460558 
Low Rs631872305305362 
Sales per share (Unadj.) Rs352.8422.592.191.6116.3 
Earnings per share (Unadj.) Rs39.256.219.214.817.9 
Diluted earnings per shareRs7.811.219.214.817.9 
Cash flow per share (Unadj.) Rs49.170.222.018.523.1 
Dividends per share (Unadj.) Rs9.0012.003.203.203.50 
Adj. dividends per shareRs1.802.403.203.203.50 
Dividend yield (eoy) %1.10.90.80.80.8 
Book value per share (Unadj.) Rs168.0220.855.768.085.4 
Adj. book value per shareRs33.644.255.768.085.4 
Shares outstanding (eoy) m204.75204.751,023.741,023.741,023.74 
Bonus/Rights/Conversions  --FV5:1-- 
Price / Sales ratio x2.43.14.14.24.0 
Avg P/E ratio x21.823.419.825.825.7 
P/CF ratio (eoy) x17.418.817.220.719.9 
Price / Book Value ratio x5.16.06.85.65.4 
Dividend payout %22.921.416.721.619.6 
Avg Mkt Cap Rs m175,061269,758388,458391,581470,664 
No. of employees `00012.213.215.416.911.8 
Total wages/salary Rs m10,71112,08512,61615,19818,545 
Avg. sales/employee Rs Th5,908.26,564.06,105.05,563.010,072.7 
Avg. wages/employee Rs Th876.0916.9817.0901.71,569.1 
Avg. net profit/employee Rs Th657.2873.01,272.1901.51,547.7 
CADILA HEALTHCARE INCOME DATA
Net Sales Rs m72,24086,51394,26893,765119,049 
Other income Rs m5075541,1561,2841,132 
Total revenues Rs m72,74787,06795,42495,049120,181 
Gross profit Rs m12,00117,59923,30519,04428,475 
Depreciation Rs m2,0122,8732,9213,7335,388 
Interest Rs m902679528446911 
Profit before tax Rs m9,59414,60121,01216,14923,308 
Minority Interest Rs m-326-397430338628 
Prior Period Items Rs m26542000 
Extraordinary Inc (Exp) Rs m-172-104-25-30 
Tax Rs m1,3252,6361,7741,2895,644 
Profit after tax Rs m8,03611,50619,64315,19518,292 
Gross profit margin %16.620.324.720.323.9 
Effective tax rate %13.818.18.48.024.2 
Net profit margin %11.113.320.816.215.4 
CADILA HEALTHCARE BALANCE SHEET DATA
Current assets Rs m34,37940,88742,80460,22382,005 
Current liabilities Rs m28,14029,92134,61053,05860,720 
Net working cap to sales %8.612.78.77.617.9 
Current ratio x1.21.41.21.11.4 
Inventory Days Days6960527073 
Debtors Days Days5769688998 
Net fixed assets Rs m40,15340,52646,98772,98483,703 
Share capital Rs m1,0241,0241,0241,0241,024 
"Free" reserves Rs m27,84544,18455,96868,57686,421 
Net worth Rs m34,39045,20856,99269,60087,445 
Long term debt Rs m13,62211,5048,96424,68425,551 
Total assets Rs m79,86591,342105,506152,207180,653 
Interest coverage x11.622.540.837.226.6 
Debt to equity ratio x0.40.30.20.40.3 
Sales to assets ratio x0.90.90.90.60.7 
Return on assets %11.213.319.110.310.6 
Return on equity %23.425.534.521.820.9 
Return on capital %21.426.133.318.022.0 
Exports to sales %27.732.547.200 
Imports to sales %5.86.26.200 
Exports (fob) Rs m20,03828,08044,53700 
Imports (cif) Rs m4,2105,3915,83800 
Fx inflow Rs m20,61329,66644,88121,28042,683 
Fx outflow Rs m6,8648,0939,06910,87411,242 
Net fx Rs m13,74921,57335,81210,40631,441 
CADILA HEALTHCARE CASH FLOW
From Operations Rs m 9,028 9,936 18,935 13,117 9,193 
From Investments Rs m -4,380 -4,647 -8,635 -28,719 -9,737 
From Financial Activity Rs m -5,287 -3,511 -9,348 23,158 515 
Net Cashflow Rs m -639 1,778 991 7,556 -29 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.8%
Foreign collaborators 0.0%
Indian inst/Mut Fund 8.3%
FIIs 5.9%
ADR/GDR 0.0%
Free float 11.0%
Shareholders 44,069
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Zydus Tower, Satellite Cross Roads, Ahmedabad - 380 015
E-MAIL upen.shah@zyduscadila.com WEB www.zyduscadila.com
TELEPHONE (079) 2686 8326 FAX (079) 2686 2365
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Sharepro Serv.,416-420, Devnandan Mall, Ellisbridge, Ahmedabad-09
AUDITOR Mukesh M. Shah & Co.
CHM: Pankaj R. Patel (MD) COMP SEC: Upen H. Shah YEAR OF INC: 1995 BSE CODE: 532321 FV (Rs): 5 DIV YIELD (%): 0.9

Read: CADILA HEALTHCARE 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   TTK HEALTHCARE  SHASUN PHARMA  MERCK LTD  WYETH LTD  SANOFI INDIA  

Compare CADILA HEALTHCARE With:   TTK HEALTHCARE  SHASUN PHARMA  MERCK LTD  WYETH LTD  SANOFI INDIA  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Nifty Hits Fresh Record High; Sensex Up Over 330 Points(12:30 pm)

After opening the day on a positive note, stock markets in India continued their momentum and went on to scale their record-high levels.

Views on news

DIVIS LABORATORIES Surges by 6%; BSE HEALTHCARE Index Up 0.7% (Market Updates)

Aug 20, 2018 | Updated on Aug 20, 2018

DIVIS LABORATORIES share price has surged by 6% and its current market price is Rs 1,247. The BSE HEALTHCARE is up by 0.7%. The top gainers in the BSE HEALTHCARE Index are DIVIS LABORATORIES (up 5.8%) and CADILA HEALTHCARE (up 5.7%). The top losers are SUN PHARMA (down 0.1%) and FDC LTD. (down 0.2%).

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Up 274.4% (Quarterly Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

For the quarter ended June 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (up 274.4% YoY). Sales on the other hand came in at Rs 29 bn (up 29.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS